NEWSROOM

Vaccine

SIBANNAC, INC. AND SPUR BIOTECH, LLC ENTER LETTER OF INTENT TO MARKET PLANT BASED VACCINE

  Scottsdale, Arizona, Jan. 18, 2022  -- McapMediaWire -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: The Company is proud to announce the entry into a Letter of Intent with SPUR Biotech, LLC (“SPUR”), an Ohio-based developer of plant-based vaccines. SPUR is a biotechnology company developing plant-based vaccines using Controlled Environment Agriculture (CEA) to sustainably grow leafy greens and biopharmaceuticals.  The vaccine under...

read more

Dyadic International (NASDAQ: DYAI): A Unique Approach to World Vaccination (DYAI, AZN, MRNA, NVAX, PFE, JNJ, BNTX)

The vaccine story is set to take yet another twist and turn in the months ahead as the Biden administration faces the literally world-shaping task of playing a material leadership role in helping to vaccinate the entire world against Covid-19. This comes after better-than-expected results in the pathway to bringing something rapidly closing in on vaccine-induced herd immunity to the United States over recent months. According to a recent piece in the Wall Street Journal, this new effort is...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »